Login / Signup

Colchicine in COVID-19: an Old Drug, New Use.

Naomi SchlesingerBonnie L FiresteinLuigi Brunetti
Published in: Current pharmacology reports (2020)
This review gives a spotlight on colchicine's anti-inflammatory and antiviral properties and why colchicine may help fight COVID-19. This review summarizes colchicine's mechanism of action via the tubulin-colchicine complex. Furthermore, it discussed how colchicine interferes with several inflammatory pathways, including inhibition of neutrophil chemotaxis, adhesion, and mobilization; disruption of superoxide production, inflammasome inhibition, and tumor necrosis factor reduction; and its possible antiviral properties. In addition, colchicine dosing and pharmacokinetics, as well as drug interactions and how they relate to ongoing, colchicine in COVID-19 clinical trials, are examined.
Keyphrases
  • coronavirus disease
  • sars cov
  • clinical trial
  • anti inflammatory
  • randomized controlled trial
  • escherichia coli
  • nitric oxide
  • respiratory syndrome coronavirus